RedHill Biopharma Announces $36 Million Strategic Investment by Cosmo Pharmaceuticals and U.S. Rights to Approved Travelers’ Diarrhea Drug AEMCOLO

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement